Journal of Epidemiology and Global Health

Volume 2, Issue 1, March 2012, Pages 57 - 60

Patterns of antituberculous drug resistance in Eastern Saudi Arabia: A 7-year surveillance study from 1/2003 to 6/2010

Authors
Liaqat Ali Chaudhrya, *, dr_liaqatali@hotmail.com, Nagamani Rambhalab, Ali Saad Al-Shammric, Jaffar A. Al-Tawfiqd
aDepartment of Medicine & Chest, Diseases, Dammam Medical Complex (MOH), Saudi Arabia
bMicrobiology Lab., Dammam Medical Complex (MOH), Saudi Arabia
cBlood Bank & Regional Lab., Dammam Medical Complex (MOH), Saudi Arabia
dSpeciality Internal Medicine, Saudi ARAMCO Medical Services Organization, Dhahran, Saudi Arabia
*Corresponding author. Address: Chief of Tuberculosis Centre, Department of Medicine & Chest, Diseases, Dammam Medical Complex (MOH), P.O. Box 132, Dammam 31411, Saudi Arabia. Tel.: +966 509949470.
Corresponding Author
Liaqat Ali Chaudhrydr_liaqatali@hotmail.com
Received 5 May 2011, Revised 15 October 2011, Accepted 20 October 2011, Available Online 24 December 2011.
DOI
10.1016/j.jegh.2011.10.001How to use a DOI?
Keywords
Incidence; Prevalence; Resistance; Eastern Saudi Arabia; Tuberculosis
Abstract

Objective: To examine the patterns of antituberculous drug resistance of Mycobacterium tuberculosis in patients with pulmonary and extra-pulmonary tuberculosis in the Eastern province of the Kingdom of Saudi Arabia.

Methods: This is a retrospective study of antibiotic susceptibility of 1681 non-repetitive M. tuberculosis isolates from 1/2003 to 6/2010.

Results: Of the total patients, 41% (n = 687) were Saudis and 59% (n = 994) were non-Saudis. The pulmonary and extra-pulmonary specimens constituted 68% (n = 1148) and 32% (n = 533), respectively. The incidence of resistance was 15.5% to one or more of anti-tuberculosis drugs. The resistance rates to first-line drugs were as follows: streptomycin (10.4%), INH (9.8%), rifampicin (1.5%) and ethambutol (1.0%). Multi-drug resistant tuberculosis was present in 1.4% (n = 24) of the sample.

Conclusion: INH resistance in this study was relatively high, whereas the rate of MDR-TB was low. A rate of MDR-TB observed in this study was 1.4%. Thus, an empiric four-drug therapy is required to treat patients with tuberculosis in this area of Saudi Arabia.

Copyright
© 2012 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
Open Access
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Download article (PDF)
View full text (HTML)

Journal
Journal of Epidemiology and Global Health
Volume-Issue
2 - 1
Pages
57 - 60
Publication Date
2011/12/24
ISSN (Online)
2210-6014
ISSN (Print)
2210-6006
DOI
10.1016/j.jegh.2011.10.001How to use a DOI?
Copyright
© 2012 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
Open Access
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Cite this article

TY  - JOUR
AU  - Liaqat Ali Chaudhry
AU  - Nagamani Rambhala
AU  - Ali Saad Al-Shammri
AU  - Jaffar A. Al-Tawfiq
PY  - 2011
DA  - 2011/12/24
TI  - Patterns of antituberculous drug resistance in Eastern Saudi Arabia: A 7-year surveillance study from 1/2003 to 6/2010
JO  - Journal of Epidemiology and Global Health
SP  - 57
EP  - 60
VL  - 2
IS  - 1
SN  - 2210-6014
UR  - https://doi.org/10.1016/j.jegh.2011.10.001
DO  - 10.1016/j.jegh.2011.10.001
ID  - AliChaudhry2011
ER  -